BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 31131509)

  • 1. Biological variation of PIVKA-II in blood serum of healthy subjects measured by automated electrochemiluminescent assay.
    Jabor A; Kubíček Z; Čásenská J; Vacková T; Filová V; Franeková J
    Pract Lab Med; 2024 Mar; 39():e00389. PubMed ID: 38576474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis.
    Chan HLY; Vogel A; Berg T; De Toni EN; Kudo M; Trojan J; Eiblmaier A; Klein HG; Hegel JK; Sharma A; Madin K; Rolny V; Lisy MR; Piratvisuth T
    JGH Open; 2022 May; 6(5):292-300. PubMed ID: 35601131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
    Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
    Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
    Lirong T; Minmin X; Manqiu Y; Yanping L
    Hippokratia; 2022; 26(2):78-82. PubMed ID: 37188051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference Range of Vitamin K Evaluating Indicators in Chinese Childbearing Women.
    Nie S; Yang L; Feng J; Lu J; Zhang H; Li W; Hu Y; Yang X
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China.
    Ji J; Liu L; Jiang F; Wen X; Zhang Y; Li S; Lou J; Wang Y; Liu N; Guo Q; Jia Y; Gao C
    J Clin Lab Anal; 2021 Nov; 35(11):e24013. PubMed ID: 34590755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A performance evaluation of chemiluminescence enzyme immunoassays on the Sysmex CN-6500 haemostasis analyser.
    Gardiner C; Lane P; Tailor H; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2021 Dec; 43(6):1593-1598. PubMed ID: 34252265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    Tartaglione S; Mancini P; Viggiani V; Chirletti P; Angeloni A; Anastasi E
    PLoS One; 2021; 16(5):e0251656. PubMed ID: 34015010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.
    Mozrzymas R; Walkowiak D; Drzymała-Czyż S; Krzyżanowska-Jankowska P; Duś-Żuchowska M; Kałużny Ł; Walkowiak J
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
    Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
    J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory assessment of vitamin K status.
    Card DJ; Gorska R; Harrington DJ
    J Clin Pathol; 2020 Feb; 73(2):70-75. PubMed ID: 31862867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Significance of Novel Serum Biomarkers in the Management of Liver Diseases].
    Inoue T; Tanaka Y
    Rinsho Byori; 2017 Jan; 65(1):83-91. PubMed ID: 30695516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
    Ryu MR; Kang ES; Park HD
    J Clin Lab Anal; 2019 Jul; 33(6):e22921. PubMed ID: 31131509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
    Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
    Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and Clinical Performance Evaluation of the Abbott Architect PIVKA Assay.
    Ko DH; Hyun J; Kim HS; Park MJ; Kim JS; Park JY; Shin DH; Cho HC
    Ann Clin Lab Sci; 2018 Jan; 48(1):75-80. PubMed ID: 29531000
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.